Our Agreements


OAPL (UK) has adopted the Publication Integrity & Ethics Guidelines for all its journals.

After consultation with our Senior Editors and Medical Director,  OAPL (UK) has taken the unilateral action of becoming the first global publishing house to adopt the PIE Guidelines.

This includes:

General P.I.E. Guidelines (PDF)

P.I.E. Guidelines for Authors (PDF)

P.I.E. Guidelines for Reviewers (PDF)

P.I.E. Guidelines for E.B. members (PDF)

P.I.E. Guidelines for Editors-in-Chief (PDF)

P.I.E. Guidelines for Publishers (PDF)

P.I.E. Guidelines on Practice-Specific Issues (PDF)

P.I.E. General Code of Conduct (PDF)

General P.I.E. Guidelines: Research integrity and ethics (PDF)

P.I.E. Guidelines: Ethical boundaries in human research (PDF)

P.I.E. Guidelines: Ethical boundaries in animal research (PDF)

P.I.E. Guidelines: Standard ethical practice in clinical research (PDF)

P.I.E. Guidelines: Clinical trials code of practice, conduct and reporting (PDF)

P.I.E. Guidelines: REC review of human-related research (PDF)



OAPL (UK) has adopted the Ethical Rules of Disclosure of the Association for Medical Ethics for all its journals.

After consultation with our chief scientific and clinical advisors OAPL (UK) has taken the unilateral action of becoming the first global publishing house to help address the perceived lack of disclosure in medicine. It is suggested that the precise amounts of money from industry received by those influencing medicine by their research and opinions are infrequently and incompletely revealed. It is felt that those holding certain positions in medicine should be expected to have limited or no financial interests. There is a paucity of explicit transparency which is strongly warranted for the sake of patient care and which should be held as the highest single priority.

We agree that:-

1. Biomedicine depends upon eliminating confounding factors/ bias.

2. It is recognised from research into unconscious and conscious persuasion that financial associations and financial inducements present incontrovertibly compelling interests that may result in unintentional bias, and potentially intentional bias.

3. The latent perception that bias could have occurred may damage the integrity of science and medicine even when there has been no confounding bias but a financial conflict has occurred.

4. Due to the real or apparent risks of bias, financial transparency regarding interests is critical for clinicians and scientists, for the public and policy makers to weigh the true validity of research findings, policy decisions, and practice guidelines developed by professional medical societies.

5. Scientists and clinicians, editorial board members, and medical society officers are viewed as a source of unbiased scientific data and education. They should have no substantive financial interest that creates unacceptable conflicts.

6. All clinicians and scientists should publicly disclose in our publications and presentations the precise nature and amount of any financial conflicting interests. Such disclosure will enhance the validity of a manuscript.



Transparency Declaration policy

OAPL (UK) is joining the academic community by implementing this Transparency Declaration policy immediately (see below). “Lead Authors” submitting their “Research Work” to OAPL journals will be expected to accept this Transparency Declaration before being able to complete the submission process. The Lead Author (manuscript’s guarantor) is defined here (by OAPL UK) as the submitting author, first author and last (senior) author. Research work is defined here (by OAPL UK) as submissions in the form of Original research studies, Research studies, Systematic reviews, Case studies, Case reports, Case series, Hypothesis, Methodology, Short communications and Study protocols. This declaration is now fully supported by OAPL (UK) and will be cited as it is in the submission system. Please see below:

Transparency declaration1
The lead author* affirms that this manuscript is an honest, accurate, and transparent account of the study being reported; that no important aspects of the study have been omitted; and that any discrepancies from the study as planned (and, if relevant, registered) have been explained.
*The manuscript’s guarantor
1Altman DG, Moher D. Declaration of transparency for each research article. BMJ 2013;347:f4796.



OAPL (UK) authors retain the copyright to their work.                                                                                            

Authors publishing with OAPL (UK) retain the copyright to their work and this is licensed under the Creative Commons Attribution License (CC-BY).

When the authors retain the copyrights to their work, they are allowed unlimited use and/or distribution of their work without any form of restriction.

In this model, articles are freely downloadable from OAPL (UK) website, OAPL (UK) journals’ websites or any website supported by OAPL (UK).

In this model, articles and data can be re-used and re-distributed without restrictions, as long as the original work of the authors is clearly and correctly identified and cited.



The British Library

OAPL (UK) is pleased to announce that the British Library is now the OAPL (UK) archiving provider. All articles published in any OAPL (UK) journal will be permanently archived by the British Library and will be searchable via its servers and downloadable in both HTML (Full Text) and PDF formats.



The EQUATOR Network

The OAPL (UK) journals follow the EQUATOR network resource centre guidance on good research reporting.




OAPL (UK) is a member of United Kingdom Serials Group (UKSG). UKSG mission is to connect the information community and encourage the exchange of ideas on scholarly communication. UKSG is the only organisation spanning the wide range of interests and activities across the scholarly information community of librarians, publishers, intermediaries and technology vendors. UKSG aims to:




OAPL (UK) is a member of CrossRef. CrossRef is an official Digital Object Identifier (DOI) Registration Agency of the International DOI Foundation. CrossRef was launched in early 2000 as a cooperative effort among publishers to enable persistent cross-publisher citation linking in online academic journals. CrossRef is a not-for-profit association of about 2000 voting member publishers who represent 4300 societies and publishers, including both commercial and not-for-profit organizations. CrossRef includes publishers with varied business models, including those with both open access and subscription policies. CrossRef does not provide a database of fulltext scientific content. Rather, it facilitates the links between distributed content hosted at other sites.



OAPL (UK) self-archiving policy

Authors may archive pre-print and post-print versions of their articles for the purpose of self-archiving or deposit.

Authors may use OAPL (UK)'s version (final PDF) for the purpose of self-archiving or deposit. The link must be accompanied by the following text: “The final HTML/PDF is also available at http://www.oapublishinglondon.com/”.



Please see The OAPL (UK) Press Centre for the most recent announcements of the Publishing Director, Medical Director and all our Senior Editors.